1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Anti-CD20 Monoclonal Antibodies Industry 2015 Market Research Report

Summary


The Global Anti-CD20 Monoclonal Antibodies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Anti-CD20 Monoclonal Antibodies industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Anti-CD20 Monoclonal Antibodies market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Anti-CD20 Monoclonal Antibodies industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 170 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Anti-CD20 Monoclonal Antibodies Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Anti-CD20 Monoclonal Antibodies
1.1.1 Definition of Anti-CD20 Monoclonal Antibodies
1.1.2 Specifications of Anti-CD20 Monoclonal Antibodies
1.2 Classification of Anti-CD20 Monoclonal Antibodies
1.3 Applications of Anti-CD20 Monoclonal Antibodies
1.4 Industry Chain Structure of Anti-CD20 Monoclonal Antibodies
1.5 Industry Overview and Major Regions Status of Anti-CD20 Monoclonal Antibodies
1.5.1 Industry Overview of Anti-CD20 Monoclonal Antibodies
1.5.2 Global Major Regions Status of Anti-CD20 Monoclonal Antibodies
1.6 Industry Policy Analysis of Anti-CD20 Monoclonal Antibodies
1.7 Industry News Analysis of Anti-CD20 Monoclonal Antibodies

2 Manufacturing Cost Structure Analysis of Anti-CD20 Monoclonal Antibodies
2.1 Raw Material Suppliers and Price Analysis of Anti-CD20 Monoclonal Antibodies
2.2 Equipment Suppliers and Price Analysis of Anti-CD20 Monoclonal Antibodies
2.3 Labor Cost Analysis of Anti-CD20 Monoclonal Antibodies
2.4 Other Costs Analysis of Anti-CD20 Monoclonal Antibodies
2.5 Manufacturing Cost Structure Analysis of Anti-CD20 Monoclonal Antibodies
2.6 Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
2.7 Global Price, Cost and Gross of Anti-CD20 Monoclonal Antibodies 2010-2015

3 Technical Data and Manufacturing Plants Analysis of Anti-CD20 Monoclonal Antibodies
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Anti-CD20 Monoclonal Antibodies Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2014

4 Production Analysis of Anti-CD20 Monoclonal Antibodies by Regions, Type, and Applications
4.1 Global Production of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015
4.2 Global Production of Anti-CD20 Monoclonal Antibodies by Type 2010-2015
4.3 Global Production of Anti-CD20 Monoclonal Antibodies by Applications 2010-2015
4.4 Price Analysis of Global Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015
4.6 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015
4.7 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015
4.8 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015

5 Consumption Volume and Consumption Value Analysis of Anti-CD20 Monoclonal Antibodies by Regions
5.1 Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015
5.2 Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015
5.3 Global Consumption Price Analysis of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015

6 Analysis of Anti-CD20 Monoclonal Antibodies Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Anti-CD20 Monoclonal Antibodies 2010-2015
6.2 Production Market Share Analysis of Anti-CD20 Monoclonal Antibodies 2010-2015
6.3 Sales Overview of Anti-CD20 Monoclonal Antibodies 2010-2015
6.4 Supply, Sales and Gap of Anti-CD20 Monoclonal Antibodies 2010-2015
6.5 Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015

7 Analysis of Anti-CD20 Monoclonal Antibodies Industry Key Manufacturers
7.1 Bayer Schering Pharma AG
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Contact Information

7.2 Biocon
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Contact Information

7.3 Biogen
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Contact Information

7.4 Eli Lilly and Company
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Contact Information

7.5 Roche
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Contact Information

7.6 Genentech
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Contact Information

7.7 Genmab A/S
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Contact Information

7.8 GlaxoSmithKline
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Contact Information

7.9 rEVO Biologics
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Contact Information

7.10 Immunomedics
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Contact Information

7.11 InNexus Biotechnology
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Contact Information

7.12 LFB Group
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Contact Information

7.13 Nycomed
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Contact Information

7.14 Pfizer
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Contact Information

7.15 Spectrum Pharmaceuticals
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Contact Information

7.16 Trubion Pharmaceuticals
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Contact Information

7.17 UCB Pharmaceutical
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Contact Information

7.18 Celltrion
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Contact Information

8 Price and Gross Margin Analysis of Anti-CD20 Monoclonal Antibodies
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Anti-CD20 Monoclonal Antibodies Product Types
8.5 Market Share Analysis of Different Anti-CD20 Monoclonal Antibodies Price Levels
8.6 Gross Margin Analysis of Different Anti-CD20 Monoclonal Antibodies Applications

9 Marketing Trader or Distributor Analysis of Anti-CD20 Monoclonal Antibodies
9.1 Marketing Channels Status of Anti-CD20 Monoclonal Antibodies
9.2 Traders or Distributors of Anti-CD20 Monoclonal Antibodies with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Anti-CD20 Monoclonal Antibodies
9.4 Regional Import, Export and Trade Analysis of Anti-CD20 Monoclonal Antibodies

10 Development Trend of Anti-CD20 Monoclonal Antibodies Industry 2016-2021
10.1 Capacity and Production Overview of Anti-CD20 Monoclonal Antibodies 2016-2021
10.2 Production Market Share Analysis of Anti-CD20 Monoclonal Antibodies 2016-2021
10.3 Sales Overview of Anti-CD20 Monoclonal Antibodies 2016-2021
10.4 Supply, Sales, and Gap of Anti-CD20 Monoclonal Antibodies 2016-2021
10.5 Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Anti-CD20 Monoclonal Antibodies 2016-2021

11 Industry Chain Suppliers with Contact Information of Anti-CD20 Monoclonal Antibodies
11.1 Major Raw Materials Suppliers with Contact Information of Anti-CD20 Monoclonal Antibodies Industry
11.2 Manufacturing Equipment Suppliers of Anti-CD20 Monoclonal Antibodies with Contact Information
11.3 Major Suppliers of Anti-CD20 Monoclonal Antibodies with Contact Information
11.4 Key Consumers of Anti-CD20 Monoclonal Antibodies with Contact Information
11.5 Supply Chain Relationship Analysis of Anti-CD20 Monoclonal Antibodies

12 New Project Investment Feasibility Analysis of Anti-CD20 Monoclonal Antibodies
12.1 New Project SWOT Analysis of Anti-CD20 Monoclonal Antibodies
12.2 New Project Investment Feasibility Analysis of Anti-CD20 Monoclonal Antibodies

13 Conclusion of the Global Anti-CD20 Monoclonal Antibodies Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Anti-CD20 Monoclonal Antibodies
Table Specifications of Anti-CD20 Monoclonal Antibodies
Table Classification of Anti-CD20 Monoclonal Antibodies
Figure Global Production Market Share of Anti-CD20 Monoclonal Antibodies by Type in 2015
Table Application Fields of Anti-CD20 Monoclonal Antibodies Products
Figure 2015 Global Anti-CD20 Monoclonal Antibodies Major Applications Sales Share
Figure Industry Chain Structure of Anti-CD20 Monoclonal Antibodies
Table Global Major Regions Anti-CD20 Monoclonal Antibodies Development Status
Table Industry Policy of Anti-CD20 Monoclonal Antibodies
Table Industry News List of Anti-CD20 Monoclonal Antibodies
Table Anti-CD20 Monoclonal Antibodies Major Raw Materials List
Table Manufacturing Cost Structure Analysis of Anti-CD20 Monoclonal Antibodies in 2014
Figure Manufacturing Process Analysis of Anti-CD20 Monoclonal Antibodies
Figure Global Price Analysis of Anti-CD20 Monoclonal Antibodies 2010-2015 (USD/Dose)
Figure Global Cost Analysis of Anti-CD20 Monoclonal Antibodies 2010-2015 (USD/Dose)
Figure Global Gross Analysis of Anti-CD20 Monoclonal Antibodies 2010-2015
Table Capacity (K Dose) and Commercial Production Date of Global Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Anti-CD20 Monoclonal Antibodies Manufacturers in 2014
Table RandD Status and Technology Source of Global Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2014
Table Global Production of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015 (K Dose)
Figure Global Production Market Share of Anti-CD20 Monoclonal Antibodies by Regions in 2014
Table Global Production of Anti-CD20 Monoclonal Antibodies by Type 2010-2015 (K Dose)
Figure Global Production Market Share of Anti-CD20 Monoclonal Antibodies by Type in 2014
Table Global Production of Anti-CD20 Monoclonal Antibodies by Applications 2010-2015 (K Dose)
Figure Global Production Market Share of Anti-CD20 Monoclonal Antibodies by Applications in 2014
Figure Price Comparison of Global Anti-CD20 Monoclonal Antibodies Key Manufacturers in 2015 (USD/Dose)
Table US Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015
Table US Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table EU Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015
Table EU Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Japan Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015
Table Japan Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table China Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015
Table China Supply, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015 (K Dose)
Figure Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions in 2010 (K Dose)
Figure Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions in 2011 (K Dose)
Figure Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions in 2012 (K Dose)
Figure Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions in 2013 (K Dose)
Figure Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions in 2014 (K Dose)
Figure Global Consumption Volume of Anti-CD20 Monoclonal Antibodies by Regions in 2015 (K Dose)
Table Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015 (M USD)
Figure Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions in 2010 (M USD)
Figure Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions in 2011 (M USD)
Figure Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions in 2012 (M USD)
Figure Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions in 2013 (M USD)
Figure Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions in 2014 (M USD)
Figure Global Consumption Value of Anti-CD20 Monoclonal Antibodies by Regions in 2015 (M USD)
Table Consumption Price of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015 (USD/Dose)
Table Global and Major Manufacturers Capacity of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Global Capacity Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers 2010-2015
Figure Global Capacity (K Dose), Production (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Figure Global Capacity Utilization Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Table Global and Major Manufacturers Revenue of Anti-CD20 Monoclonal Antibodies 2010-2015 (M USD)
Table Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Table China and Major Manufacturers Capacity of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Capacity Market Share of China Major Anti-CD20 Monoclonal Antibodies Manufacturers 2010-2015
Table China and Major Manufacturers Production of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Production Market Share of China Major Anti-CD20 Monoclonal Antibodies Manufacturers 2010-2015
Figure China Capacity (K Dose), Production (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Figure China Capacity Utilization Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Table China and Major Manufacturers Revenue of Anti-CD20 Monoclonal Antibodies 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2010
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2011
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2012
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2013
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2014
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2015
Figure China Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2010
Figure China Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2011
Figure China Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2012
Figure China Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2013
Figure China Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2014
Figure China Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2015
Figure Global Sales (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Figure China Sales (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2010-2015
Table Global Supply, Sales and Gap of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table China Supply, Sales and Gap of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table China Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2010-2015 (K Dose)
Table Price of Global Anti-CD20 Monoclonal Antibodies Major Manufacturers 2010-2015 (USD/Dose)
Figure Price Comparison by Global Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2014 (USD/Dose)
Table Gross Margin of Global Anti-CD20 Monoclonal Antibodies Major Manufacturers 2010-2015
Figure Gross Margin of Global Anti-CD20 Monoclonal Antibodies Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Anti-CD20 Monoclonal Antibodies 2010-2015 (M USD)
Table Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2011
Figure Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2012
Figure Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2013
Figure Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2014
Figure Global Revenue Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2015
Table China and Major Manufacturers Revenue of Anti-CD20 Monoclonal Antibodies 2010-2015 (M USD)
Table Revenue Market Share of China Anti-CD20 Monoclonal Antibodies Major Manufacturers 2010-2015
Table Global Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015
Table China Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Bayer Schering Pharma AG
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer Schering Pharma AG 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Bayer Schering Pharma AG 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Bayer Schering Pharma AG 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Biocon
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Biocon 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Biocon 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Biogen Idec
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biogen Idec 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Biogen Idec 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Biogen Idec 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Eli Lilly and Company
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly and Company 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Eli Lilly and Company 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Eli Lilly and Company 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Roche?
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche? 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Roche? 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Roche? 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Genentech
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Genentech 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Genentech 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Genentech 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Genmab A/S
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Genmab A/S 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Genmab A/S 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Genmab A/S 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of GlaxoSmithKline
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of GlaxoSmithKline 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of GlaxoSmithKline 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of rEVO Biologics?
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of rEVO Biologics? 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of rEVO Biologics? 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of rEVO Biologics? 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Immunomedics
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Immunomedics 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Immunomedics 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Immunomedics 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of InNexus Biotechnology
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of InNexus Biotechnology 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of InNexus Biotechnology 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of InNexus Biotechnology 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of LFB Group
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of LFB Group 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of LFB Group 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of LFB Group 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Nycomed
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Nycomed 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Nycomed 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Nycomed 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Pfizer
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Pfizer 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Pfizer 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Spectrum Pharmaceuticals
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Spectrum Pharmaceuticals 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Spectrum Pharmaceuticals 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Spectrum Pharmaceuticals 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Trubion Pharmaceuticals
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Trubion Pharmaceuticals 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Trubion Pharmaceuticals 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Trubion Pharmaceuticals 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of UCB Pharmaceutical
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of UCB Pharmaceutical 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of UCB Pharmaceutical 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of UCB Pharmaceutical 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Picture and Specifications of Celltrion
Table Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Capacity (K Dose), Production (K Dose) and Growth Rate of Celltrion 2010-2015
Figure Anti-CD20 Monoclonal Antibodies Production (K Dose) and Global Market Share of Celltrion 2010-2015
Table Gross Margin of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015
Table Price Comparison of Anti-CD20 Monoclonal Antibodies by Regions 2010-2015 (USD/Dose)
Table Price of Different Anti-CD20 Monoclonal Antibodies Product Types (USD/Dose)
Table Market Share of Different Anti-CD20 Monoclonal Antibodies Price Level
Table Gross Margin of Different Anti-CD20 Monoclonal Antibodies Applications
Table Traders or Distributors of Anti-CD20 Monoclonal Antibodies with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Anti-CD20 Monoclonal Antibodies (USD/Dose)
Table Regional Import, Export, and Trade of Anti-CD20 Monoclonal Antibodies (K Dose)
Figure Global Capacity (K Dose), Production (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2016-2021
Figure Global Capacity Utilization Rate of Anti-CD20 Monoclonal Antibodies 2016-2021
Figure China Capacity (K Dose), Production (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2016-2021
Figure China Capacity Utilization Rate of Anti-CD20 Monoclonal Antibodies 2016-2021
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2016
Figure Global Production Market Share of Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2021
Figure Production Market Share of China Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2016
Figure Production Market Share of China Major Anti-CD20 Monoclonal Antibodies Manufacturers in 2021
Figure Global and China Sales (K Dose) and Growth Rate of Anti-CD20 Monoclonal Antibodies 2016-2021
Table Global Supply, Sales and Gap of Anti-CD20 Monoclonal Antibodies 2016-2021 (K Dose)
Table China Supply, Sales and Gap of Anti-CD20 Monoclonal Antibodies 2016-2021 (K Dose)
Table China Production, Import, Export and Consumption of Anti-CD20 Monoclonal Antibodies 2016-2021 (K Dose)
Table Global Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2016-2021
Table China Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-CD20 Monoclonal Antibodies 2016-2021
Table Major Raw Materials Suppliers with Contact Information of Anti-CD20 Monoclonal Antibodies
Table Manufacturing Equipment Suppliers of Anti-CD20 Monoclonal Antibodies with Contact Information
Table Major Suppliers of Anti-CD20 Monoclonal Antibodies with Contact Information
Table Key Consumers of Anti-CD20 Monoclonal Antibodies with Contact Information
Figure Supply Chain Relationship Analysis of Anti-CD20 Monoclonal Antibodies
Table New Project SWOT Analysis of Anti-CD20 Monoclonal Antibodies
Table New Project Investment Feasibility Analysis of Anti-CD20 Monoclonal Antibodies
Table Part of Interviewees Record List


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024

Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global monoclonal antibodies (mAbs) market was valued at USD 85.4 billion in 2015 and is expected to reach a value of USD 138.6 billion by 2024. Increasing R&D pertaining to the development of therapeutic ...

Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2016 Market Research Report

Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Monoclonal Antibody ...

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Antibody Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.